The Australian Technical Advisory Group on Immunisation (ATAGI) has released a statement on booster doses in adolescents aged 12-15 years.
Following their review of evidence on the benefits and risks of a booster dose of Pfizer COVID-19 vaccine in adolescents in Australia aged 12-15 years, ATAGI does not recommend that adolescents aged 12-15 years need to receive a booster dose of Pfizer COVID-19 vaccine and will continue to review international evidence on efficacy of a booster in this age group.
ATAGI continue to strongly recommend vaccination of all young people aged 5 to 15 years with 2 primary doses of a COVID-19 vaccine, including those who may have previously had COVID-19. 3 primary doses are recommended for those in this age group who are severely immunocompromised.
For more information please refer to the link below:
ATAGI statement on use of booster doses in adolescents aged 12-15 years